Differences

This shows you the differences between two versions of the page.

--- teams:chemotherapy:start [2023/08/03 09:46] – created chk
+++ teams:chemotherapy:start [2023/08/03 16:32] (current) – chk
@@ Line 1: / Line 1: @@
 ====== Chemotherapy of Mycoplasma Infections ======
   * Team Leader: Florence Tardy (France)
+  * Vision of the IRPCM chemotherapy group:
+    * Ascertain and reduce antimicrobial resistance levels in mollicutes to protect global human and animals for the future
+    * Coordinating international agreed standards for MIC of mollicute species
+    * Mapping global resistance of mollicutes of human and veterinary importance
+    * Reducing unnecessary use of antimicrobials and promoting good stewardship
+    * Understanding the molecular mechanisms of resistance
+    * Evaluation of new and alternative agents
+  * Current Goals:
+    * To standardize veterinary mycoplasma antimicrobial sensitivity testing, including control strains and methodology like it was done for human mycoplasmas.
+    * To continue work on molecular determinants of antimicrobial resistance
+    * Identifying breakpoints
+    * Epidemiological surveillance
+    * Monitoring of antimicrobial resistance
+    * Development of the molecular assay to track antimicrobial resistance in the real-time
+    * Molecular typing of strains with different susceptibility
+    * Evaluation of new and alternative chemotherapeutic agents